Sevinç is a health economist with consulting and research experience across pharmaceutical market access, HTA, and reimbursement strategy in European markets. Delivered Global Value Dossier and cost-effectiveness work for global clients, strategic advisory on disease-modifying therapy adoption at Trinity College Dublin, and independent modelling engagements for pharmaceutical clients. Built Ireland’s first published health economic models for Alzheimer’s DMTs. Strong methodological foundation in cost-effectiveness and budget impact modelling, with working knowledge of major European HTA frameworks. Seeking to contribute to market access strategy and innovative reimbursement solutions in a multi-disciplinary advisory team.